Show simple item record

dc.contributor.authorGarg, M
dc.contributor.authorRoyce, SG
dc.contributor.authorLubel, JS
dc.date.accessioned2020-12-16T23:37:06Z
dc.date.available2020-12-16T23:37:06Z
dc.date.issued2020-06-03
dc.identifier.citationGarg, M., Royce, S. G. & Lubel, J. S. (2020). Letter: intestinal inflammation, COVID-19 and gastrointestinal ACE2-exploring RAS inhibitors. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 52 (3), pp.569-570. https://doi.org/10.1111/apt.15814.
dc.identifier.issn0269-2813
dc.identifier.urihttp://hdl.handle.net/11343/254419
dc.languageEnglish
dc.publisherWILEY
dc.titleLetter: intestinal inflammation, COVID-19 and gastrointestinal ACE2-exploring RAS inhibitors
dc.typeJournal Article
dc.identifier.doi10.1111/apt.15814
melbourne.affiliation.departmentClinical Pathology
melbourne.affiliation.departmentMedicine and Radiology
melbourne.source.titleAlimentary Pharmacology and Therapeutics
melbourne.source.volume52
melbourne.source.issue3
melbourne.source.pages569-570
melbourne.elementsid1448682
melbourne.openaccess.urlhttps://europepmc.org/articles/PMC7267165?pdf=render
melbourne.openaccess.statusPublished version
melbourne.contributor.authorRoyce, Simon
melbourne.contributor.authorGarg, Mayur
dc.identifier.eissn1365-2036
melbourne.accessrightsAccess this item via the Open Access location


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record